[HTML][HTML] The Epidemiology of first and second-line drug-resistance Mycobacterium tuberculosis complex common species: Evidence from selected TB treatment …
B Dagne, K Desta, R Fekade, M Amare, M Tadesse… - PLoS …, 2021 - journals.plos.org
Background Drug-resistance in Mycobacterium tuberculosis complex remains a major
health burden in human history and still is a major leading cause of death in developing …
health burden in human history and still is a major leading cause of death in developing …
[PDF][PDF] The Epidemiology of first and second-line drug-resistance Mycobacterium tuberculosis complex common species: Evidence from selected TB treatment …
B Dagne, K Desta, R Fekade, M Amare, M Tadesse… - PLoS ONE, 2021 - researchgate.net
Background Drug-resistance in Mycobacterium tuberculosis complex remains a major
health burden in human history and still is a major leading cause of death in developing …
health burden in human history and still is a major leading cause of death in developing …
The Epidemiology of first and second-line drug-resistance Mycobacterium tuberculosis complex common species: Evidence from selected TB treatment initiating …
B Dagne, K Desta, R Fekade, M Amare… - PLoS …, 2021 - search.ebscohost.com
Abstract Background: Drug-resistance in Mycobacterium tuberculosis complex remains a
major health burden in human history and still is a major leading cause of death in …
major health burden in human history and still is a major leading cause of death in …
[PDF][PDF] The Epidemiology of first and second-line drug-resistance Mycobacterium tuberculosis complex common species: Evidence from selected TB treatment …
B Dagne, K Desta, R Fekade, M Amare, M Tadesse… - PLoS ONE, 2021 - scholar.archive.org
Background Drug-resistance in Mycobacterium tuberculosis complex remains a major
health burden in human history and still is a major leading cause of death in developing …
health burden in human history and still is a major leading cause of death in developing …
[PDF][PDF] The Epidemiology of first and second-line drug-resistance Mycobacterium tuberculosis complex common species: Evidence from selected TB treatment …
B Dagne, K Desta, R Fekade, M Amare… - PLoS …, 2021 - pdfs.semanticscholar.org
Background Drug-resistance in Mycobacterium tuberculosis complex remains a major
health burden in human history and still is a major leading cause of death in developing …
health burden in human history and still is a major leading cause of death in developing …
[HTML][HTML] The Epidemiology of first and second-line drug-resistance Mycobacterium tuberculosis complex common species: Evidence from selected TB treatment …
B Dagne, K Desta, R Fekade, M Amare, M Tadesse… - PLoS ONE, 2021 - ncbi.nlm.nih.gov
Background Drug-resistance in Mycobacterium tuberculosis complex remains a major
health burden in human history and still is a major leading cause of death in developing …
health burden in human history and still is a major leading cause of death in developing …
[引用][C] The Epidemiology of first and second-line drug-resistance Mycobacterium tuberculosis complex common species: Evidence from selected TB treatment …
B Dagne, K Desta, R Fekade, M Amare… - PLoS …, 2021 - ui.adsabs.harvard.edu
The Epidemiology of first and second-line drug-resistance Mycobacterium tuberculosis
complex common species: Evidence from selected TB treatment initiating centers in …
complex common species: Evidence from selected TB treatment initiating centers in …
[PDF][PDF] The Epidemiology of first and second-line drug-resistance Mycobacterium tuberculosis complex common species: Evidence from selected TB treatment …
B Dagne, K Desta, R Fekade, M Amare, M Tadesse… - PLoS ONE, 2021 - academia.edu
PLOS ONE Page 1 RESEARCH ARTICLE The Epidemiology of first and second-line drug-resistance
Mycobacterium tuberculosis complex common species: Evidence from selected TB treatment …
Mycobacterium tuberculosis complex common species: Evidence from selected TB treatment …
The Epidemiology of first and second-line drug-resistance Mycobacterium tuberculosis complex common species: Evidence from selected TB treatment initiating …
B Dagne, K Desta, R Fekade, M Amare… - PloS …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Drug-resistance in Mycobacterium tuberculosis complex remains a major
health burden in human history and still is a major leading cause of death in developing …
health burden in human history and still is a major leading cause of death in developing …
The Epidemiology of first and second-line drug-resistance Mycobacterium tuberculosis complex common species: Evidence from selected TB treatment initiating …
B Dagne, K Desta, R Fekade, M Amare, M Tadesse… - Plos one, 2021 - europepmc.org
Background Drug-resistance in Mycobacterium tuberculosis complex remains a major
health burden in human history and still is a major leading cause of death in developing …
health burden in human history and still is a major leading cause of death in developing …